Expression and Function of EPLIN
Expression and Function of EPLIN
批准号:
6438889
负责人:
David D. Chang
金额:
$33.99万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-10 至 2007-12-31
中文摘要
描述:(申请人提供)EPLIN是一种转录水平的基因
在癌细胞中表达下调。它编码一种新的LIM结构域蛋白,该蛋白
与细胞骨架结构共定位。已知的亚型有两种
EPLIN(阿尔法和贝塔),由替代启动子用法从
单拷贝基因位于染色体12q13。Eplin的表达为
在一些上皮癌细胞中发生改变,包括几个前列腺癌
癌细胞系、异种移植和肿瘤。EPLIN的过度表达可能会改变
细胞内的肌动蛋白纤维和抑制NIH3T3细胞的锚定非依赖性生长
Cdc42或EWS/Fli-1转化的细胞。纯化的EPLIN可以结合丝状结构
肌动蛋白和改变肌动蛋白的体外聚合。EPLIN的精确功能
Eplin的表达与转化之间的关系尚不清楚。
然而,EPLIN的已知特征表明,这
细胞骨架相关蛋白可能在细胞周期调控中发挥作用
细胞骨架。我们认为Eplin具有调节肌动蛋白的功能
通过将肌动蛋白细丝连接到其他结构或
调节蛋白。因此,EPLIN的中断将改变
并损害细胞与细胞和/或细胞与基质的相互作用。我们
假设EPLIN中的异常可能在
通过扰乱上皮腺和上皮腺的组织来进展癌症
促进细胞迁移。这笔赠款的具体目的将检验我们的想法
通过研究(I)EPLIN的生化性质;(II)EPLIN在体内的作用
正常细胞和癌细胞;(Iii)Eplin在胚胎发生和发育过程中的作用
组织动态平衡。
英文摘要
DESCRIPTION: (provided by applicant) EPLIN is a gene that is transcriptionally
downregulated in cancer cells. It encodes a novel LIM domain protein that
co-localizes with the cytoskeletal structures. There are two known isoforms of
EPLIN (alpha and beta), generated by an alternative promoter usage from a
single copy gene located in chromosome 12q13. The expression of EPLIN is
altered in a number of epithelial cancer cells, including several prostate
cancer cell lines, xenografts, and tumors. Overexpression of EPLIN can alter
actin fibers in the cell and inhibit anchorage independent growth of NIH3T3
cells transformed by Cdc42 or EWS/Fli-1. Purified EPLIN can bind filamentous
actin and alter actin polymerization in vitro. The precise function of EPLIN
and the relationship between EPLIN expression and transformation are not known.
However, the known characteristics of EPLIN suggest that this
cytoskeleton-associated protein may play a role in the regulation of the
cytoskeleton. We believe that EPLIN functions to regulate the actin
cytoskeleton in the cell by linking actin filaments to other structural or
regulatory proteins. The disruption of EPLIN would therefore alter
cytoarchitecture and impair cell-cell and/or cell-matrix interaction. We
postulate that abnormalities in EPLIN could potentially play a role during
progression of cancer by disrupting the organization of epithelial glands and
promoting cell migration. The specific aims of this grant will test our ideas
by studying (i) biochemical properties of EPLIN; (ii) function of EPLIN in
normal and cancer cells; (iii) function of EPLIN during embryogenesis and in
tissue homeostasis.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Pseudoaneuploid subpopulations detected in normal upper aerodigestive tract mucosa consistent with physiological apoptosis in normally differentiating squamous mucosa.
在正常上呼吸消化道粘膜中检测到的假非整倍体亚群与正常分化的鳞状粘膜中的生理性细胞凋亡一致。
DOI:
10.1016/j.otohns.2004.04.036
发表时间:
2004
期刊:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
影响因子:
--
作者:
[El-Rayes,BassilF, Korkmaz,Hakan, Maciorowski,Zosia, Sakr,Wael, Jacobs,JohnR, Ensley,JohnF]
通讯作者:
Ensley,JohnF
EPLIN regulates actin dynamics by cross-linking and stabilizing filaments.
Eplin通过交联和稳定细丝来调节肌动蛋白动力学。
DOI:
10.1083/jcb.200212057
发表时间:
2003-02-03
期刊:
JOURNAL OF CELL BIOLOGY
影响因子:
7.8
作者:
[Maul, Raymond S, Song, Yuhong, Amann, Kurt J, Gerbin, Sachi C, Pollard, Thomas D, Chang, David D]
通讯作者:
Chang, David D
ICAPL AND BETA 1 INTEGRIN SIGNALING
-
批准号:6376815
-
项目类别:
-
资助金额:$19.77万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
TRANSFORMATION RELATED GENES IN ORAL CANCERS
-
批准号:6019505
-
项目类别:
-
资助金额:$10.71万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
ICAPL AND BETA 1 INTEGRIN SIGNALING
-
批准号:2896553
-
项目类别:
-
资助金额:$18.96万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
ICAPL AND BETA 1 INTEGRIN SIGNALING
-
批准号:6174250
-
项目类别:
-
资助金额:$19.36万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
ICAPL AND BETA 1 INTEGRIN SIGNALING
-
批准号:2670430
-
项目类别:
-
资助金额:$18.94万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
ICAPL AND BETA 1 INTEGRIN SIGNALING
-
批准号:6513265
-
项目类别:
-
资助金额:$20.2万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
TRANSFORMATION RELATED GENES IN ORAL CANCERS
-
批准号:2688160
-
项目类别:
-
资助金额:$10.47万
-
财政年份:1998
-
负责人:David D. Chang
-
依托单位:
海外基金